News DexCare raises $75m for digital patient booking system DexCare has topped up its finances with a $75 million third round that will be used to fund the continued roll-out of its patient appointment booking platform.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.